Patents and regulatory exclusivities on GLP-1 receptor agonists
Importance Glucagon-like peptide 1 (GLP-1) receptor agonists were first approved for the
treatment of type 2 diabetes in 2005. Demand for these drugs has increased rapidly in …
treatment of type 2 diabetes in 2005. Demand for these drugs has increased rapidly in …
[HTML][HTML] Patent and marketing exclusivities 101 for drug developers
B Oronsky, S Caroen, F Brinkhaus, T Reid… - Recent Patents on …, 2023 - ncbi.nlm.nih.gov
Despite an ever-increasing need for newer, safer, more effective, and more affordable
therapies to treat a multitude of diseases and conditions, drug development takes too long …
therapies to treat a multitude of diseases and conditions, drug development takes too long …
Patent Challenges And Litigation On Inhalers For Asthma And COPD: Study examines patent challenges and litigation involving inhalers for asthma and COPD
Between 1986 and 2020 the Food and Drug Administration (FDA) approved fifty-three brand-
name inhalers for asthma and chronic obstructive pulmonary disease (COPD), but by the …
name inhalers for asthma and chronic obstructive pulmonary disease (COPD), but by the …
The prevalence of post-NDA drug patents and their relationship to the timing of generic approval
JJ Darrow, V Van de Wiele, B Brown… - nature …, 2024 - nature.com
The prevalence of post-NDA drug patents and their relationship to the timing of generic approval
| Nature Biotechnology Skip to main content Thank you for visiting nature.com. You are using a …
| Nature Biotechnology Skip to main content Thank you for visiting nature.com. You are using a …
Repositioning Generic Drugs: Empirical Findings and Policy Implications
Commentators claim that drug repositioning (ie developing new uses for authorised drugs)
significantly slows when generics are authorised and, therefore, law reform is necessary to …
significantly slows when generics are authorised and, therefore, law reform is necessary to …
Comparative Toxicity of Interferon Beta-1a Impurities of Heavy Metal Ions
D Berillo - Medicina, 2022 - mdpi.com
Background and Objectives: Providing a proper quality control of drugs is essential for
efficient treatment of various diseases minimizing the possible side effects of pharmaceutical …
efficient treatment of various diseases minimizing the possible side effects of pharmaceutical …
[引用][C] Factores que Predisponen y la Satisfacción del Usuario Respecto al Consumo de Medicamentos Genéricos, Botica F&C Farma, Lima–2024.
R Flores Julca, RY Bonilla Loyola - 2024 - Universidad Privada de Huancayo …